ABO and Alzheimer disease: To evaluate the efficacy of 6H4 Fabs encapsulated in the PMs on AD pathology, we evaluated the quantitative and histochemical changes of these toxic Aβ species after long-term peripheral administration of anti-AβO 6H4 Fabs encapsulated in the PMs in AD model mice at the age of amyloid plaque deposition in the brain.